TGA expectations for overseas manufacturing sites hosting remote inspections during the COVID-19 pandemic
Information to assist overseas manufactures who may undergo a remote Good Manufacturing Practice (GMP) inspection during the COVID-19 pandemic.
- Conducting domestic inspections during the Coronavirus (COVID-19) pandemic
- Due to changes in travel restrictions, all overseas GMP inspections and QMS audits have now been suspended until further notice
- Information updated following the cessation of the Therapeutic Goods (Medical Devices—Accredited Pathology Laboratories) (COVID-19 Emergency) Exemption 2020